Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Cancer Genet ; 264-265: 40-49, 2022 06.
Article in English | MEDLINE | ID: mdl-35354106

ABSTRACT

Variants of unknown significance (VUS) remain a constant challenge in the diagnosis of hereditary cancer and the counseling of patients with pedigrees suggestive of such a syndrome. In order to assess some of this limitation, several variants in the DNA repair gene ATM were selected from a cohort of high risk individuals with negative genetic diagnoses. ATM has proven a challenge in the counseling of patients due to its nature as a moderate penetrance gene. In this study, six ATM missense mutations with a high likelihood for pathogenicity were assessed through a battery of experiments to yield high fidelity information on their biochemical effect on ATM activity. We report that several of these variants show signs of reduced ATM function indicative of likely pathogenicity. With further study, this data may be used in clinic, improving diagnosis, surveillance, and outcome for patients carrying these mutations.


Subject(s)
Breast Neoplasms , Neoplasms , Ataxia Telangiectasia Mutated Proteins/genetics , Breast Neoplasms/genetics , Cohort Studies , Female , Genetic Predisposition to Disease , Humans , Mutation/genetics , Neoplasms/genetics , Pedigree , Penetrance
2.
Immunol Cell Biol ; 93(5): 452-60, 2015.
Article in English | MEDLINE | ID: mdl-25582340

ABSTRACT

The HECT-type E3 ligase Itch is increasingly being shown to have a vital role in immune regulation. Itch deficiency leads to deleterious inflammatory disorders both in mice and humans. By adding ubiquitin to the key signaling intermediates, Itch functions as a critical regulator of lymphocyte-cell activation, differentiation and immune tolerance. Also, Itch cooperates with deubiquitinating enzymes such as A20 and Cyld to terminate NF-κB signaling and prevent chronic inflammation. This review summarizes recent advances that highlight Itch's role in lymphocyte function and explores recent insights regarding its role as a regulator of inflammatory signaling.


Subject(s)
Inflammation/immunology , Repressor Proteins/metabolism , Ubiquitin-Protein Ligases/metabolism , Animals , Cell Differentiation/genetics , DNA-Binding Proteins/metabolism , Deubiquitinating Enzyme CYLD , Humans , Immunomodulation , Intracellular Signaling Peptides and Proteins/metabolism , Lymphocyte Activation/genetics , Mice , NF-kappa B/antagonists & inhibitors , Nuclear Proteins/metabolism , Repressor Proteins/genetics , Signal Transduction/genetics , Tumor Necrosis Factor alpha-Induced Protein 3 , Tumor Suppressor Proteins/metabolism , Ubiquitin-Protein Ligases/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...